Sorilux

Active Ingredient(s): Calcipotriene
FDA Approved: * October 6, 2010
Pharm Company: * STIEFEL LABS INC
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Sorilux Overview

Calcipotriol, also known as calcipotriene, is a synthetic derivative of calcitriol, a form of vitamin D. It is used in the treatment of psoriasis. It is safe for long-term application in psoriatic skin conditions. It was patented in 1985 and approved for medical use in 1991.[1] It is marketed under the trade name "Dovonex" in the United States, "Daivonex" outside North America, and "Psorcutan" in Germany. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Inter...

Read more Sorilux Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Calcipotriol

Recent Sorilux Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Sorilux: (2 results)

Sorted by National Drug Code

• 0145-2130 Sorilux 50 ug/g Topical Aerosol, Foam by Stiefel Laboratories Inc
• 51862-376 Sorilux 50 ug/g Topical Aerosol, Foam by Mayne Pharma LLC

Other drugs which contain Calcipotriene or a similar ingredient: (8 results)

• CALCIPOTRIENE
• DOVONEX Calcipotriene
• BETAMETHASONE DIPROPIONATE + CALCIPOTRIENE HYDRATE
• CALCIPOTRIENE + BETAMETHASONE DIPROPIONATE
• ENSTILAR Calcipotriene + Betamethasone Dipropionate
• TACLONEX Betamethasone Dipropionate + Calcipotriene Hydrate
• TACLONEX SCALP Calcipotriene + Betamethasone Dipropionate
• WYNZORA Betamethasone Dipropionate + Calcipotriene